Canada Pension Plan Investment Board
JANX icon

Canada Pension Plan Investment Board’s Janux Therapeutics JANX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Hold
11,500
– – ﹤0.01% 1620
2026
Q1 		$160K Buy
+11,500
New +$158K ﹤0.01% 1606

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Canada Pension Plan Investment Board's JANX Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Janux Therapeutics (JANX) position steady in Q2 2026 at 11,500 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Canada Pension Plan Investment Board first reported a position in JANX in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Canada Pension Plan Investment Board held 11,500 shares of Janux Therapeutics worth $177K as of Q2 2026.
  • Canada Pension Plan Investment Board left its Janux Therapeutics share count unchanged in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1620 holding.
  • Canada Pension Plan Investment Board first reported a position in Janux Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.